ClassID:

95252

C07D403/12 - page 11 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#3001
20170320828
2017-11-09

Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

#3002
20170319578
2017-11-09

Compounds and their use as BACE inhibitors

#3003
20170319551
2017-11-09

Nuclear transport modulators and uses thereof

#3004
20170313732
2017-11-02

Annelated phenoxyacetamides

#3005
20170313717
2017-11-02

GLP-1 receptor modulators

#3006
20170313714
2017-11-02

EGFR inhibitor, preparation method and use thereof

#3007
20170313712
2017-11-02

Diheteroaryl histone deacetylase inhibitors and their use in therapy

#3008
20170313708
2017-11-02

Nonanoic and decanoic acid derivatives and uses thereof

#3009
20170313690
2017-11-02

Modulators of calcium release-activated calcium channel

#3010
20170313675
2017-11-02

Heteroarylamide inhibitors of TBK1

#3011
20170312279
2017-11-02

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors

#3012
20170305918
2017-10-26

Dual-warhead covalent inhibitors of FGFR-4

#3013
20170305892
2017-10-26

Aminopyridine compounds useful as inhibitors of protein prenylation

#3014
20170305864
2017-10-26

Heterocyclic compounds as pesticides

#3015
20170305824
2017-10-26

SMALL MOLECULE INHIBITORS OF NECROPTOSIS

#3016
20170304305
2017-10-26

QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF

#3017
20170298085
2017-10-19

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#3018
20170298084
2017-10-19

Amide compounds for treatment of complement mediated disorders

#3019
20170298082
2017-10-19

Glycosidase inhibitors

#3020
20170298058
2017-10-19

HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE

#3021
20170298054
2017-10-19

Compositions and methods for inhibition of the JAK pathway

#3022
20170298027
2017-10-19

Pyrimidines as sodium channel blockers

#3023
20170291917
2017-10-12

Kinase inhibitors

#3024
20170291897
2017-10-12

Therapeutic compounds as inhibitors of the orexin-1 receptor

#3025
20170291888
2017-10-12

1,2,4-triazine-4-amine derivatives

#3026
20170290830
2017-10-12

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#3027
20170290828
2017-10-12

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#3028
20170283442
2017-10-05

Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules

#3029
20170283427
2017-10-05

Compounds for the inhibition of cyclophilins and uses thereof

#3030
20170283425
2017-10-05

COMPOUNDS FOR THE INHIBITION OF CYCLOPHILINS AND USES THEREOF

#3031
20170283403
2017-10-05

Diamide macrocycles that are FXIa inhibitors

#3032
20170283398
2017-10-05

2-aminopyrimidine compound and pharmaceutical composition and use thereof

#3033
20170281626
2017-10-05

PYRIMIDINEDIONE COMPOUNDS

#3034
20170275301
2017-09-28

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#3035
20170275291
2017-09-28

Indazole compounds as FGFR kinase inhibitor, preparation and use thereof

#3036
20170275289
2017-09-28

Therapeutic compounds and uses thereof

#3037
20170275253
2017-09-28

Benzazepine sulfonamide compounds

#3038
20170275249
2017-09-28

SMALL LIPOPEPTIDOMIMETIC INHIBITORS OF GHRELIN O-ACYL TRANSFERASE

#3039
20170273943
2017-09-28

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#3040
20170271597
2017-09-21

Organic electroluminescent element, display device, lighting device, PI-conjugated compound, and light-emitting thin film

#3041
20170267696
2017-09-21

Certain protein kinase inhibitors

#3042
20170267663
2017-09-21

Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

#3043
20170267648
2017-09-21

SUBSTITUTED URACILS AS CHYMASE INHIBITORS

#3044
20170267647
2017-09-21

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#3045
20170267643
2017-09-21

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#3046
20170267634
2017-09-21

Compounds as CRTH2 antagonist and uses thereof

#3047
20170266181
2017-09-21

Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity

#3048
20170266160
2017-09-21

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

#3049
20170260207
2017-09-14

Biaryl amide compounds as kinase inhibitors

#3050
20170260206
2017-09-14

Androgen receptor modulating compounds

#3051
20170260195
2017-09-14

Sulfoximine substituted quinazolines for pharmaceutical compositions

#3052
20170260143
2017-09-14

Compounds

#3053
20170260136
2017-09-14

Heteroaryl orexin receptor antagonists

#3054
20170253591
2017-09-07

Heterocyclic compound

#3055
20170253562
2017-09-07

Nampt Inhibitors

#3056
20170252317
2017-09-07

N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

#3057
20170247392
2017-08-31

ALK kinase inhibitor, and preparation method and uses thereof

#3058
20170247388
2017-08-31

Inhibitors of IRAK4 activity

#3059
20170247376
2017-08-31

Methods and compositions for inhibition of Ras

#3060
20170247365
2017-08-31

Compounds

#3061
20170247341
2017-08-31

PHARMACEUTICALLY ACTIVE PYRAZINE DERIVATIVES

#3062
20170247340
2017-08-31

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

#3063
20170247336
2017-08-31

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

#3064
20170247327
2017-08-31

Octahydrocyclopentapyrroles, their preparation and use

#3065
20170247326
2017-08-31

Substituted Pyrrolidine Carboxamide Compounds

#3066
20170246196
2017-08-31

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

#3067
20170246167
2017-08-31

2,4-pyrimidinediamine compounds and their uses

#3068
20170240540
2017-08-24

3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1)-one derivatives as fungicides

#3069
20170240538
2017-08-24

G protein-coupled receptor kinase 2 inhibitors and methods for use of the same

#3070
20170240514
2017-08-24

Small molecule agonists of neurotensin receptor 1

#3071
20170240512
2017-08-24

Heterocycle and carbocycle derivatives having TrkA inhibitory activity

#3072
20170239245
2017-08-24

Pyrimidine derivatives for the treatment of viral infections

#3073
20170233377
2017-08-17

Heterocyclic compounds as NaV channel inhibitors and uses thereof

#3074
20170233374
2017-08-17

T-type calcium channel modulator and uses thereof

#3075
20170233340
2017-08-17

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

#3076
20170232113
2017-08-17

Quaternary amine compounds and antibody-drug conjugates thereof

#3077
20170226127
2017-08-10

Compounds, compositions and methods

#3078
20170226124
2017-08-10

PHTHALAZINONE DERIVATIVES

#3079
20170226099
2017-08-10

Quinazoline derivative

#3080
20170226097
2017-08-10

Pyridinyloxy- and phenyloxy-pyrazolyl compounds

#3081
20170226095
2017-08-10

Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging

#3082
20170226091
2017-08-10

2,2,2-trifluoroethyl-thiadiazines

#3083
20170226090
2017-08-10

Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

#3084
20170226089
2017-08-10

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

#3085
20170226083
2017-08-10

Forms and compositions of an ERK inhibitor

#3086
20170226080
2017-08-10

Pyrrolidinone derivatives as MetAP-2 inhibitors

#3087
20170226065
2017-08-10

Potent dual BRD4-kinase inhibitors as cancer therapeutics

#3088
20170224689
2017-08-10

Pyrrolopyrimidine compounds as inhibitors of protein kinases

#3089
20170224653
2017-08-10

TLR-independent small molecule adjuvants

#3090
20170218353
2017-08-03

Ligand-directed covalent modification of protein

#3091
20170217981
2017-08-03

Inhibitors of IRAK4 activity

#3092
20170217974
2017-08-03

Hepatitis B antiviral agents

#3093
20170217961
2017-08-03

Pyrimidine-2,4-diamine derivatives for treatment of cancer

#3094
20170217951
2017-08-03

Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof

#3095
20170217950
2017-08-03

Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same

#3096
20170217941
2017-08-03

SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

#3097
20170217937
2017-08-03

Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same

#3098
20170217936
2017-08-03

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

#3099
20170217908
2017-08-03

Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis

#3100
20170217905
2017-08-03

Aminopyrimidine derivatives for use as modulators of kinase activity

#3101
20170217885
2017-08-03

SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#3102
20170210759
2017-07-27

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#3103
20170210756
2017-07-27

Synthesis of an antiviral compound

#3104
20170210734
2017-07-27

Substituted azaspiro(4.5)decane derivatives

#3105
20170210729
2017-07-27

ERK inhibitors and uses thereof

#3106
20170210725
2017-07-27

6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same

#3107
20170210713
2017-07-27

Pyrimidine carboxamides as sodium channel blockers

#3108
20170210712
2017-07-27

Process for preparing pyrazoles

#3109
20170210700
2017-07-27

3-aryl propiolonitrile compounds for thiol labeling

#3110
20170204085
2017-07-20

BIOCIDAL COATINGS AND METHODS FOR MAKING SAME

#3111
20170204084
2017-07-20

4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity

#3112
20170204070
2017-07-20

Inhibitors of histone deacetylase

#3113
20170202984
2017-07-20

Compositions, methods, and systems for the synthesis and use of imaging agents

#3114
20170197983
2017-07-13

Heterocyclic compounds having cholesterol 24-hydroxylase activity

#3115
20170197981
2017-07-13

Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

#3116
20170197978
2017-07-13

Heteroaryl substituted compounds as RORγ inhibitors

#3117
20170197976
2017-07-13

MTH1 inhibitors for treatment of cancer

#3118
20170197971
2017-07-13

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#3119
20170197943
2017-07-13

Process for producing alkynylketone derivative

#3120
20170197923
2017-07-13

Bifunctional compounds and use for reducing uric acid levels

#3121
20170197919
2017-07-13

3-(Carboxyethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#3122
20170197915
2017-07-13

Estrogen receptor modulators and uses thereof

#3123
20170190711
2017-07-06

Urea and amide derivatives of aminoalkylpiperazines and use thereof

#3124
20170190691
2017-07-06

5-acylsulfanyl-histidine compounds as precursors of the corresponding 5-sulfanylhistidines and their disulfides

#3125
20170190687
2017-07-06

Imidazol- or 1,2,4-triazol-derivatives and their use

#3126
20170190671
2017-07-06

BIS(ARYL)CATECHOL DERIVATIVES AS HERBICIDES

#3127
20170190669
2017-07-06

Pyrazole compounds and methods of making and using same

#3128
20170189410
2017-07-06

Amino compounds for treatment of complement mediated disorders

#3129
20170189399
2017-07-06

Neprilysin inhibitors

#3130
20170183332
2017-06-29

Heterocyclic amides as kinase inhibitors

#3131
20170183330
2017-06-29

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

#3132
20170182050
2017-06-29

Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production

#3133
20170174704
2017-06-22

Quinoxaline compounds and uses thereof

#3134
20170174700
2017-06-22

Biotin Derivatives

#3135
20170174691
2017-06-22

Protein kinase conjugates and inhibitors

#3136
20170174689
2017-06-22

Substituted indole Mcl-1 inhibitors

#3137
20170174678
2017-06-22

Antiviral compounds and methods using same

#3138
20170174673
2017-06-22

Pyridazine compounds as JAK inhibitors

#3139
20170174652
2017-06-22

Inhibitors of the fibroblast growth factor receptor

#3140
20170173017
2017-06-22

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

#3141
20170166577
2017-06-15

Apelin receptor (APJ) agonists and uses thereof

#3142
20170166563
2017-06-15

2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors

#3143
20170166560
2017-06-15

Five-membered heterocycles useful as serine protease inhibitors

#3144
20170166557
2017-06-15

6-substituted quinazolinone inhibitors

#3145
20170166533
2017-06-15

Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

#3146
20170166524
2017-06-15

N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

#3147
20170165263
2017-06-15

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

#3148
20170159100
2017-06-08

Water-soluble activatable molecular probes, intermediates for the synthesis thereof and associated detection methods

#3149
20170158704
2017-06-08

Pyrimidinone derivative having autotaxin-inhibitory activity

#3150
20170158702
2017-06-08

MULTIVALENT RAS BINDING COMPOUNDS

#3151
20170158698
2017-06-08

TrKA kinase inhibitors, compositions and methods thereof

#3152
20170158692
2017-06-08

Compounds and methods for inhibiting fascin

#3153
20170158686
2017-06-08

Substituted pyrimidines for inhibiting Raf kinase activity

#3154
20170158685
2017-06-08

Histone demethylase inhibitors

#3155
20170158677
2017-06-08

Substituted indazole derivatives active as kinase inhibitors

#3156
20170158673
2017-06-08

Quinazolinone derivatives as PARP inhibitors

#3157
20170157135
2017-06-08

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

#3158
20170157124
2017-06-08

Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use

#3159
20170157092
2017-06-08

Anti-depression compounds

#3160
20170152252
2017-06-01

TRPV1 vanilloid receptor antagonists with a bicyclic portion

#3161
20170152249
2017-06-01

Benzimidazole derivatives as kinase inhibitors

#3162
20170152233
2017-06-01

Amino quinazolines as kinase inhibitors

#3163
20170152232
2017-06-01

NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND

#3164
20170152230
2017-06-01

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#3165
20170151353
2017-06-01

Compositions, methods, and systems for the synthesis and use of imaging agents

#3166
20170145038
2017-05-25

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#3167
20170145019
2017-05-25

Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors

#3168
20170145007
2017-05-25

Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient

#3169
20170144994
2017-05-25

Substituted azetidine derivatives

#3170
20170143672
2017-05-25

Tetrazole-substituted arylamides as PXand PXantagonists

#3171
20170137430
2017-05-18

Nuclear Transport Modulators And Uses Thereof

#3172
20170137411
2017-05-18

Compositions and methods for inhibition of the JAK pathway

#3173
20170137405
2017-05-18

Compounds for the treatment of HIV

#3174
20170137402
2017-05-18

Inhibitors of lysine specific demethylase-1

#3175
20170137388
2017-05-18

Neprilysin inhibitors

#3176
20170136018
2017-05-18

Methods for treating MS using pyrimidine and pyridine compounds with BTK inhibitory activity

#3177
20170129877
2017-05-11

Cyclic amine azaheterocyclic carboxamides

#3178
20170129862
2017-05-11

Tetrazolones as a carboxylic acid bioisosteres

#3179
20170129861
2017-05-11

6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides

#3180
20170121346
2017-05-04

Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2

#3181
20170121313
2017-05-04

Compounds

#3182
20170121292
2017-05-04

HIV REPLICATION INHIBITING PYRIMIDINES

#3183
20170121291
2017-05-04

COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY

#3184
20170121282
2017-05-04

Auristatin derivatives and conjugates thereof

#3185
20170119765
2017-05-04

2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis

#3186
20170119753
2017-05-04

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

#3187
20170118983
2017-05-04

Tetrazolinone compound and application thereof

#3188
20170117482
2017-04-27

Compound and organic light-emitting device including the same

#3189
20170114083
2017-04-27

Compounds and compositions as kinase inhibitors

#3190
20170114071
2017-04-27

TrkA kinase inhibitors, compositions and methods thereof

#3191
20170114060
2017-04-27

NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME

#3192
20170114055
2017-04-27

Histone demethylase inhibitors

#3193
20170114050
2017-04-27

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

#3194
20170114045
2017-04-27

Phenyl triazole derivative and its use for modulating the GABAreceptor complex

#3195
20170114033
2017-04-27

Water-soluble triazabutadienes

#3196
20170114024
2017-04-27

Inhibitors of lysine specific demethylase-1

#3197
20170112833
2017-04-27

Tyrosine kinase inhibitor and uses thereof

#3198
20170112832
2017-04-27

Treatment of GVHD

#3199
20170107226
2017-04-20

Dihydroxy aromatic heterocyclic compound

#3200
20170107211
2017-04-20

Benzimidazole compounds and medical uses thereof

#3201
20170107207
2017-04-20

AMINOPYRAZOLONE DERIVATIVE

#3202
20170107204
2017-04-20

TrkA kinase inhibitors, compositions and methods thereof

#3203
20170107203
2017-04-20

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#3204
20170107202
2017-04-20

Compounds useful as immunomodulators

#3205
20170107178
2017-04-20

Indole derivatives for use in medicine

#3206
20170105415
2017-04-20

Tetrazolinone compound and application thereof

#3207
20170098776
2017-04-06

Anthracene derivative, light-emitting element using the same, and light-emitting device using the same

#3208
20170096421
2017-04-06

Carboxamide derivatives and use thereof

#3209
20170096416
2017-04-06

Pyrazole-substituted arylamides as P2Xand P2Xantagonists

#3210
20170096406
2017-04-06

Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease

#3211
20170096405
2017-04-06

Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same

#3212
20170096404
2017-04-06

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#3213
20170096399
2017-04-06

Pyrazole compounds and their use as T-type calcium channel blockers

#3214
20170092889
2017-03-30

Light-Emitting Element, Display Device, Electronic Device, and Lighting Device

#3215
20170088544
2017-03-30

Substituted indol-5-ol derivatives and their therapeutical applications

#3216
20170088524
2017-03-30

Compositions, methods of use, and methods of treatment

#3217
20170088523
2017-03-30

Benzimidazole derivatives and uses thereof

#3218
20170087156
2017-03-30

1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor

#3219
20170081315
2017-03-23

Phenyl and benzodioxinyl substituted indazoles derivatives

#3220
20170081314
2017-03-23

Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto

#3221
20170081312
2017-03-23

ANTIVIRAL COMPOUNDS

#3222
20170081290
2017-03-23

2,4-pyrimidinediamine compounds and their uses

#3223
20170079952
2017-03-23

Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure

#3224
20170073333
2017-03-16

Pyrazolyl-substituted heteroaryls and their use as medicaments

#3225
20170073332
2017-03-16

Treatments for gastrointestinal conditions

#3226
20170073331
2017-03-16

Guanidine compounds and use thereof

#3227
20170073328
2017-03-16

Multivalent ligands targeting VEGFR

#3228
20170073327
2017-03-16

Crystal form of dabigatran etexilate mesylate and preparation method and use thereof

#3229
20170073316
2017-03-16

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#3230
20170073315
2017-03-16

Methods of regioselective synthesis of 2,4-disubstituted pyrimidines

#3231
20170073314
2017-03-16

Human plasma kallikrein inhibitors

#3232
20170073313
2017-03-16

Benzomorphan analogs and use thereof

#3233
20170071943
2017-03-16

Treatment of brain and central nervous system tumors

#3234
20170071942
2017-03-16

CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

#3235
20170071919
2017-03-16

Pyridine and pyrazine derivative for the treatment of CF

#3236
20170071906
2017-03-16

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

#3237
20170066782
2017-03-09

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

#3238
20170066755
2017-03-09

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#3239
20170066745
2017-03-09

Herbicidal compounds

#3240
20170066744
2017-03-09

1,2-substituted cyclopentanes as orexin receptor antagonists

#3241
20170066718
2017-03-09

Urea derivative or pharmacologically acceptable salt thereof

#3242
20170066717
2017-03-09

NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS

#3243
20170065582
2017-03-09

Combinations for the treatment of neuroblastoma

#3244
20170065574
2017-03-09

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#3245
20170065569
2017-03-09

Fumarate analogs and uses thereof

#3246
20170062733
2017-03-02

Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device

#3247
20170062728
2017-03-02

Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof

#3248
20170057957
2017-03-02

2,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof

#3249
20170057953
2017-03-02

Compositions useful for treating disorders related to kit

#3250
20170057926
2017-03-02

Arginine methyltransferase inhibitors and uses thereof

#3251
20170050992
2017-02-23

NOVEL ANNELATED PHENOXYACETAMIDES

#3252
20170050979
2017-02-23

Small molecule inhibitors of G protein coupled receptor 6 kinases polypeptides

#3253
20170050964
2017-02-23

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#3254
20170050960
2017-02-23

NEW BICYCLIC DERIVATIVES

#3255
20170050952
2017-02-23

Annelated benzamides

#3256
20170050949
2017-02-23

Uracil derivatives as AXL and c-MET kinase inhibitors

#3257
20170050942
2017-02-23

3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS

#3258
20170050937
2017-02-23

COMPOUNDS AND THERAPEUTICAL USE THEREOF

#3259
20170050936
2017-02-23

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#3260
20170050926
2017-02-23

Benzamide compounds and related methods of use

#3261
20170049750
2017-02-23

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3262
20170044174
2017-02-16

Heterocyclic compounds and their use as dopamine D1 ligands

#3263
20170044133
2017-02-16

2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof

#3264
20170044115
2017-02-16

Disubstituted 1, 2, 4-triazine compound

#3265
20170044112
2017-02-16

Hydrophobically tagged janus kinase inhibitors and uses thereof

#3266
20170044111
2017-02-16

Janus kinase inhibitors and uses thereof

#3267
20170044100
2017-02-16

INHIBITORS OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS

#3268
20170037034
2017-02-09

JAK1 inhibitors

#3269
20170037004
2017-02-09

ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#3270
20170035747
2017-02-09

Nitrogen-containing heteroaryl compounds and methods of use thereof

#3271
20170029442
2017-02-02

Heterocyclic compounds and uses thereof

#3272
20170029425
2017-02-02

Diazaspirocycloalkane and azaspirocycloalkane

#3273
20170029412
2017-02-02

Enhancer of zeste homolog 2 inhibitors

#3274
20170029411
2017-02-02

Antibacterial 1-indazole and 1-indole derivatives

#3275
20170029409
2017-02-02

Compositions useful for treating disorders related to kit

#3276
20170029386
2017-02-02

N-alkoxyamide conjugates as imaging agents

#3277
20170029381
2017-02-02

Tetrahydro-benzoimidazolyl modulators of TGR5

#3278
20170022218
2017-01-26

Condensed 5-oxazolidinone derivative

#3279
20170022192
2017-01-26

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

#3280
20170022191
2017-01-26

Benzamides

#3281
20170022186
2017-01-26

Halogenated quinazolin-THF-amines as PDE1 inhibitors

#3282
20170020904
2017-01-26

Neprilysin inhibitors

#3283
20170020886
2017-01-26

Amido-substituted azole compounds

#3284
20170018720
2017-01-19

Spiro compound having azafluorene ring structure, light-emitting material, and organic electroluminescent device

#3285
20170015658
2017-01-19

Hepatitis B core protein allosteric modulators

#3286
20170015633
2017-01-19

Pyrimidone carboxamide compounds as PDE2 inhibitors

#3287
20170015631
2017-01-19

PKM2 modulators and methods for their use

#3288
20170015629
2017-01-19

Azepane derivatives and methods of treating hepatitis B infections

#3289
20170014381
2017-01-19

Somatostatin receptor subtype 4 (SSTR4) agonists

#3290
20170008884
2017-01-12

Cysteine protease inhibitors and uses thereof

#3291
20170008880
2017-01-12

Neprilysin inhibitors

#3292
20170008878
2017-01-12

Heterocyclic amides as kinase inhibitors

#3293
20170008877
2017-01-12

Bicyclic lactams and methods of use thereof

#3294
20170008857
2017-01-12

Heteroaryl compounds as BTK inhibitors and uses thereof

#3295
20170007610
2017-01-12

NOVEL HETEROBICYCLIC COMPOUNDS AS KAPPA OPIOID AGONISTS

#3296
20170007604
2017-01-12

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors

#3297
20170007601
2017-01-12

Pyrimidine FGFR4 inhibitors

#3298
20170002016
2017-01-05

Azaspiro derivatives as TRPM8 antagonists

#3299
20170001998
2017-01-05

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#3300
20170001988
2017-01-05

PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER